Page:United States Statutes at Large Volume 117.djvu/758

From Wikisource
Jump to navigation Jump to search
This page needs to be proofread.

[117 STAT. 739]
PUBLIC LAW 107-000—MMMM. DD, 2003
[117 STAT. 739]

PUBLIC LAW 108–25—MAY 27, 2003

117 STAT. 739

(3) the number of participants placed, the countries in which they were placed, and why those countries were selected; and (4) the potential for expansion of the program. (h) AUTHORIZATION OF APPROPRIATIONS.— (1) IN GENERAL.—In addition to amounts otherwise available for such purpose, there are authorized to be appropriated to the President, from amounts authorized to be appropriated under section 401, such sums as may be necessary for each of the fiscal years 2004 through 2008 to carry out the program. (2) AVAILABILITY OF FUNDS.—Amounts appropriated pursuant to the authorization of appropriations under paragraph (1) are authorized to remain available until expended. SEC. 305. REPORT ON TREATMENT ACTIVITIES BY RELEVANT EXECUTIVE BRANCH AGENCIES.

22 USC 7635.

(a) IN GENERAL.—Not later than 15 months after the date of enactment of this Act, the President shall submit to appropriate congressional committees a report on the programs and activities of the relevant executive branch agencies that are directed to the treatment of individuals in foreign countries infected with HIV or living with AIDS. (b) REPORT ELEMENTS.—The report shall include— (1) a description of the activities of relevant executive branch agencies with respect to— (A) the treatment of opportunistic infections; (B) the use of antiretrovirals; (C) the status of research into successful treatment protocols for individuals in the developing world; (D) technical assistance and training of local health care workers (in countries affected by the pandemic) to administer antiretrovirals, manage side effects, and monitor patients’ viral loads and immune status; (E) the status of strategies to promote sustainability of HIV/AIDS pharmaceuticals (including antiretrovirals) and the effects of drug resistance on HIV/AIDS patients; and (F) the status of appropriate law enforcement officials working to ensure that HIV/AIDS pharmaceutical treatment is not diminished through illegal counterfeiting and black market sales of such pharmaceuticals; (2) information on existing pilot projects, including a discussion of why a given population was selected, the number of people treated, the cost of treatment, the mechanisms established to ensure that treatment is being administered effectively and safely, and plans for scaling up pilot projects (including projected timelines and required resources); and (3) an explanation of how those activities relate to efforts to prevent the transmission of the HIV infection.

President. Deadline.

SEC. 306. STRATEGIES TO IMPROVE INJECTION SAFETY.

Section 307 of the Public Health Service Act (42 U.S.C. 242l) is amended by adding at the end the following: ‘‘(d) In carrying out immunization programs and other programs in developing countries for the prevention, treatment, and control of infectious diseases, including HIV/AIDS, tuberculosis, and

VerDate 11-MAY-2000

13:45 Aug 26, 2004

Jkt 019194

PO 00000

Frm 00765

Fmt 6580

Sfmt 6581

D:\STATUTES\2003\19194PT1.001

APPS10

PsN: 19194PT1